FBLG FibroBiologics, Inc.

Fundamentals / CIK 0001958777 / USD

FibroBiologics, Inc. reported $6.75M in total assets and a net loss of $16.41M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FBLG in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$17.43MFY 2022 Net Income: -$5.12M2022FY 2023 Net Income: -$16.48M2023FY 2024 Net Income: -$11.16M2024FY 2025 Net Income: -$18.65M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $7.41M $4.50M $2.37M $1.15M
Total Operating Expenses $16.65M $13.74M $8.89M $4.47M
Operating Income -$16.65M -$13.74M -$8.89M -$4.47M
EBITDA -$16.41M -$13.58M -$8.84M --
Interest Income $247K $251K -- --
Interest Expense $204K $20K $147K $654K
Income Tax Expense $0 $0 $0 $0
Net Income -$18.65M -$11.16M -$16.48M -$5.12M
Basic EPS -$8.40 -$6.80 -$13.60 -$3.60
Diluted EPS -$8.40 -$6.80 -$13.60 -$3.60
Basic Shares Outstanding 2.2M 1.6M 1.4M 1.4M
Diluted Shares Outstanding 2.2M 1.6M 1.4M 1.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.08M $1.66M $2.95M $797K $2.79M $2.04M $1.78M $1.36M
Total Operating Expenses $4.07M $4.03M $5.07M $2.59M $5.04M $4.49M $4.53M $3.71M
Operating Income -$4.07M -$4.03M -$5.07M -$2.59M -$5.04M -$4.49M -$4.53M -$3.71M
EBITDA -$4.00M -$3.97M -$5.00M -$2.52M -$4.97M -$4.43M -$4.48M -$3.67M
Interest Income $20K $15K $20K $25K $73K $50K $99K $63K
Interest Expense $4.0K $7.0K $4.0K $204K $0 $0 $0 $6.0K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 --
Net Income -$4.05M -$4.12M -$5.00M -$3.24M -$5.78M -$4.66M -$4.97M -$3.10M
Basic EPS -$0.38 -$0.66 -$1.33 -- -$2.68 -$2.41 -$2.71 --
Diluted EPS -$0.38 -$0.66 -$1.33 -- -$2.68 -$2.41 -$2.71 --
Basic Shares Outstanding 10.6M 6.3M 3.8M -- 2.2M 1.9M 1.8M --
Diluted Shares Outstanding 10.6M 6.3M 3.8M -- 2.2M 1.9M 1.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $4.89M $13.98M $9.16M $2.27M
Cash & Short-Term Investments $4.89M $13.98M $9.16M $2.27M
Accounts Receivable, Net -- -- -- $300K
Other Current Assets $0 $18K $16K $30K
Total Current Assets $6.35M $14.23M $9.21M $2.62M
Property, Plant & Equipment, Net $842K $824K $797K --
Total Non-Current Assets $3.27M $2.22M $2.61M $2.20M
Total Assets $9.62M $16.45M $11.82M $4.82M
Total Current Liabilities $1.76M $12.73M $9.18M $7.07M
Total Non-Current Liabilities $1.70M $984K $1.39M $1.75M
Total Liabilities $3.46M $13.71M $10.57M $8.82M
Total Debt (incl. Leases) $2.41M $1.39M $1.75M $2.07M
Common Stock $1.0K $0 -- $10.00M
Retained Earnings -$54.16M -$35.52M -$24.36M -$7.87M
Total Stockholders' Equity $6.16M $2.73M $1.25M -$4.00M
Total Equity $6.16M $2.73M $1.25M -$4.00M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $1.17M $3.52M $1.48M $4.89M $4.87M $8.85M $8.67M $13.98M
Cash & Short-Term Investments $1.17M $3.52M $1.48M $4.89M $4.87M $8.85M $8.67M $13.98M
Other Current Assets -- -- $403K $0 -- -- $18K $18K
Total Current Assets $4.78M $5.85M $2.90M $6.35M $5.24M $10.18M $9.33M $14.23M
Property, Plant & Equipment, Net $661K $710K $776K $842K $908K $967K $814K $824K
Total Non-Current Assets $1.97M $2.08M $3.03M $3.27M $3.50M $3.73M $2.10M $2.22M
Total Assets $6.75M $7.93M $5.94M $9.62M $8.74M $13.91M $11.43M $16.45M
Total Current Liabilities $3.93M $2.21M $1.83M $1.76M $6.72M $10.96M $8.21M $12.73M
Total Non-Current Liabilities $1.01M $1.08M $1.51M $1.70M $1.90M $2.08M $865K $984K
Total Liabilities $4.94M $3.29M $3.34M $3.46M $8.62M $13.05M $9.08M $13.71M
Total Debt (incl. Leases) $1.27M $1.34M $2.23M $2.41M $2.54M $2.71M $1.28M $1.39M
Common Stock $1.0K $1.0K $1.0K $1.0K $0 $0 -- $0
Retained Earnings -$67.33M -$63.28M -$59.16M -$54.16M -$50.92M -$45.14M -$40.48M -$35.52M
Total Stockholders' Equity $1.81M $4.64M $2.60M $6.16M $125K $860K $2.35M $2.73M
Total Equity $1.81M $4.64M $2.60M $6.16M $125K $860K $2.35M $2.73M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$18.65M -$11.16M -$16.48M -$5.12M
Depreciation & Amortization $244K $157K $47K --
Stock-Based Compensation $2.69M $2.22M $1.76M $265K
Operating Cash Flow -$16.39M -$11.90M -$6.40M -$4.07M
Capital Expenditure -$262K -$184K -$495K --
Free Cash Flow -$16.66M -$12.09M -$6.90M --
Investing Cash Flow -$262K -$184K -$495K --
Common Stock Issued $6.59M $7.51M $16.42M --
Financing Cash Flow $7.57M $16.91M $13.79M $5.92M
Net Change in Cash -$9.09M $4.82M $6.90M $1.86M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.05M -$4.12M -$5.00M -$3.24M -$5.78M -$4.66M -$4.97M -$3.10M
Depreciation & Amortization $66K $66K $66K $66K $65K $60K $53K $47K
Stock-Based Compensation $671K $707K $694K $702K $704K $729K $551K $544K
Operating Cash Flow -$2.75M -$3.29M -$4.36M -$3.16M -$3.97M -$3.98M -$5.28M -$3.07M
Capital Expenditure -$18K $0 $0 $0 -$6.0K -$213K -$43K -$99K
Free Cash Flow -$2.77M -$3.29M -$4.36M -$3.16M -$3.98M -$4.20M -$5.32M -$3.17M
Investing Cash Flow -$18K $0 $0 $0 -$6.0K -$213K -$43K -$99K
Common Stock Issued $550K $2.86M $706K $6.59M $0 $0 $0 $45K
Financing Cash Flow $426K $5.32M $952K $3.19M $0 $4.38M $0 $9.33M
Net Change in Cash -$2.35M $2.03M -$3.41M $27K -$3.98M $178K -$5.32M $6.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -302.9% -408.1% -1315.6% --
Return on Assets (ROA) -193.8% -67.9% -139.5% -106.2%
Current Ratio 3.61x 1.12x 1.00x 0.37x
Quick Ratio 2.78x 1.10x 1.00x 0.36x
Debt to Equity 0.39x 0.51x 1.39x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -907.1% -391.3% -718.5% -302.9% -14800.8% -1537.6% -326.3% -408.1%
Return on Assets (ROA) -243.1% -228.8% -314.6% -193.8% -211.6% -95.1% -67.1% -67.9%
Current Ratio 1.22x 2.64x 1.59x 3.61x 0.78x 0.93x 1.14x 1.12x
Quick Ratio 0.30x 1.59x 0.81x 2.78x 0.72x 0.81x 1.06x 1.10x
Debt to Equity 0.70x 0.29x 0.86x 0.39x 20.32x 3.15x 0.54x 0.51x
Net Income Growth (YoY) -- -- -- -- -- -618.7% -- --
EPS Growth (YoY) -- -- -- -- -- -501.7% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001958777) · from December 31, 2022 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal